RBM11
Splicing regulator RBM11
Also known as: RBM11_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P57052
- Gene
- RBM11
- Ensembl
- ENSG00000185272
- Chromosome
- 21
- Canonical length
- 281 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables poly(U) RNA binding activity and protein homodimerization activity. Acts upstream of or within cellular response to oxidative stress and regulation of alternative mRNA splicing, via spliceosome. Located in nuclear speck. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
281 residues, UniProt reviewed canonical sequence.
>P57052|RBM11
1 MFPAQEEADR TVFVGNLEAR VREEILYELF LQAGPLTKVT ICKDREGKPK SFGFVCFKHP
61 ESVSYAIALL NGIRLYGRPI NVQYRFGSSR SSEPANQSFE SCVKINSHNY RNEEMLVGRS
121 SFPMQYFPIN NTSLPQEYFL FQKMQWHVYN PVLQLPYYEM TAPLPNSASV SSSLNHVPDL
181 EAGPSSYKWT HQQPSDSDLY QMTAPLPNSA SVSSSLNHVP DLEAGPSSYK WTHQQPSDSD
241 LYQMNKRKRQ KQTSDSDSST DNNRGNECSQ KFRKSKKKKR YLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RBM11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 43 nTPM
- spinal cord: 6.1 nTPM
- hypothalamus: 2.9 nTPM
- cerebral cortex: 2.7 nTPM
- hippocampal formation: 2.7 nTPM
- midbrain: 2.4 nTPM
Single-cell type
- epididymal principal cells: 425 nCPM
- oocytes: 74 nCPM
- other brain neurons: 20 nCPM
- epididymal basal cells: 20 nCPM
- corticotrophs: 19 nCPM
- retinal horizontal cells: 18 nCPM
Immune cell
- naive CD4 T-cell: 1.2 nTPM
- naive CD8 T-cell: 0.3 nTPM
- memory CD4 T-cell: 0.2 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- white matter: 2.5 nTPM
- pons: 2.3 nTPM
- midbrain: 2.2 nTPM
- basal ganglia: 2 nTPM
- hypothalamus: 1.8 nTPM
- medulla oblongata: 1.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.17
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.38
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- cellular response to oxidative stress
- mRNA processing
- regulation of alternative mRNA splicing, via spliceosome
- RNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RBM11 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RBM11 as an antibody target. Whether an autoantibody or antibody against RBM11 could matter depends on whether native RBM11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RBM11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RBM11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...